Literature DB >> 33399535

Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection.

Anastasia A Minervina1, Ekaterina A Komech1, Aleksei Titov2, Meriem Bensouda Koraichi3, Elisa Rosati4, Ilgar Z Mamedov1, Andre Franke4, Grigory A Efimov2, Dmitriy M Chudakov1, Thierry Mora5, Aleksandra M Walczak3, Yuri B Lebedev1, Mikhail V Pogorelyy1.   

Abstract

COVID-19 is a global pandemic caused by the pan class="Species">SARS-CoV-2 coronavirus. T cells play a key role in the adaptive antiviral immune response by killing infected cells and facilitating the selection of virus-specific antibodies. However neither the dynamics and cross-reactivity of the SARS-CoV-2-specific T cell response nor the diversity of resulting immune memory are well understood. In this study we use longitudinal high-throughput T cell receptor (TCR) sequencing to track changes in the T cell repertoire following two mild cases of COVID-19. In both donors we identified CD4+ and CD8+ T cell clones with transient clonal expansion after infection. The antigen specificity of CD8+ TCR sequences to SARS-CoV-2 epitopes was confirmed by both MHC tetramer binding and presence in large database of SARS-CoV-2 epitope-specific TCRs. We describe characteristic motifs in TCR sequences of COVID-19-reactive clones and show preferential occurence of these motifs in publicly available large dataset of repertoires from COVID-19 patients. We show that in both donors the majority of infection-reactive clonotypes acquire memory phenotypes. Certain T cell clones were detected in the memory fraction at the pre-infection timepoint, suggesting participation of pre-existing cross-reactive memory T cells in the immune response to SARS-CoV-2.
© 2021, Minervina et al.

Entities:  

Keywords:  computational biology; human; immunology; inflammation; systems biology

Year:  2021        PMID: 33399535     DOI: 10.7554/eLife.63502

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  27 in total

1.  Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses.

Authors:  Olga Lyudovyk; Justin Y Kim; David Qualls; Madeline A Hwee; Ya-Hui Lin; Sawsan R Boutemine; Yuval Elhanati; Alexander Solovyov; Melanie Douglas; Eunise Chen; N Esther Babady; Lakshmi Ramanathan; Pallavi Vedantam; Chaitanya Bandlamudi; Sigrid Gouma; Philip Wong; Scott E Hensley; Benjamin Greenbaum; Alexander C Huang; Santosha A Vardhana
Journal:  Cancer Cell       Date:  2022-05-30       Impact factor: 38.585

2.  Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery.

Authors:  Mikhail V Pogorelyy; Elisa Rosati; Anastasia A Minervina; Robert C Mettelman; Alexander Scheffold; Andre Franke; Petra Bacher; Paul G Thomas
Journal:  Cell Rep Med       Date:  2022-07-01

Review 3.  A review of COVID-19 biomarkers and drug targets: resources and tools.

Authors:  Francesca P Caruso; Giovanni Scala; Luigi Cerulo; Michele Ceccarelli
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

4.  TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients.

Authors:  Jorn L J C Assmann; P Martijn Kolijn; Benjamin Schrijver; Adriaan J van Gammeren; Daan W Loth; Ton A A M Ermens; Willem A Dik; Vincent H J van der Velden; Anton W Langerak
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

5.  T cell response to SARS-CoV-2 infection in humans: A systematic review.

Authors:  Madhumita Shrotri; May C I van Schalkwyk; Nathan Post; Danielle Eddy; Catherine Huntley; David Leeman; Samuel Rigby; Sarah V Williams; William H Bermingham; Paul Kellam; John Maher; Adrian M Shields; Gayatri Amirthalingam; Sharon J Peacock; Sharif A Ismail
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

6.  Antibody response to SARS-CoV-2 infection in humans: A systematic review.

Authors:  Nathan Post; Danielle Eddy; Catherine Huntley; May C I van Schalkwyk; Madhumita Shrotri; David Leeman; Samuel Rigby; Sarah V Williams; William H Bermingham; Paul Kellam; John Maher; Adrian M Shields; Gayatri Amirthalingam; Sharon J Peacock; Sharif A Ismail
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

7.  Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.

Authors:  Che-Mai Chang; Po-Hao Feng; Tsung-Hsun Wu; Houda Alachkar; Kang-Yun Lee; Wei-Chiao Chang
Journal:  J Clin Immunol       Date:  2021-05-05       Impact factor: 8.317

8.  The Future of Blood Testing Is the Immunome.

Authors:  Ramy A Arnaout; Eline T Luning Prak; Nicholas Schwab; Florian Rubelt
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

9.  iCAT: diagnostic assessment tool of immunological history using high-throughput T-cell receptor sequencing.

Authors:  Ahmad Rajeh; Kyle Wolf; Courtney Schiebout; Nabeel Sait; Tim Kosfeld; Richard J DiPaolo; Tae-Hyuk Ahn
Journal:  F1000Res       Date:  2021-02-03

10.  SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells.

Authors:  Anastasia A Minervina; Mikhail V Pogorelyy; Allison M Kirk; Jeremy Chase Crawford; E Kaitlynn Allen; Ching-Heng Chou; Robert C Mettelman; Kim J Allison; Chun-Yang Lin; David C Brice; Xun Zhu; Kasi Vegesana; Gang Wu; Sanchit Trivedi; Pratibha Kottapalli; Daniel Darnell; Suzanne McNeely; Scott R Olsen; Stacey Schultz-Cherry; Jeremie H Estepp; Maureen A McGargill; Joshua Wolf; Paul G Thomas
Journal:  medRxiv       Date:  2022-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.